Skip to main content

Find Clinical Trials

Home
Conditions
Dyslipidemias

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

1,824 public trials 142 recruiting studies

Refine in advanced search Browse all conditions

Dyslipidemias trial results

Recruiting

A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

NCT07543731

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +15 more
Locations: Novartis Basel, Switzerland

View Trial Details

Recruiting

A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins

NCT07634484

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: NTT Medical Center Sapporo Hokkaido, Japan

Ami Higashi Clinic Ibaraki, Japan

Olive Takamatsu Medical Clinic Kagawa, Japan

Medical Corporation Shintokai Yokohama Minoru Clinic Kanagawa, Japan

View Trial Details

Recruiting

Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance

NCT06684106

Conditions: Dyslipidemias, Glucose Intolerance, Glucose Metabolism Disorders, +8 more
Locations: Department of Cardiology, First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China

The First Affiliated Hospital of Xi 'an Jiaotong University Xi'an, China

View Trial Details

Recruiting

An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia

NCT06974266

Conditions: Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
Locations: PKUCare Luzhong Hospital Zibo, Shandong, China

View Trial Details

Recruiting

Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia

NCT07662330

Conditions: Body Weight, Dyslipidemias, Hyperlipidemia, +11 more
Locations: Shanghai Tenth People'S Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants

NCT07608705

Conditions: Dyslipidemias, Hyperlipidemias, Lipid Metabolism Disorders, +2 more
Locations: Qilu Hospital of Shandong University Jinan, Shandong, China

View Trial Details

Recruiting

A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors

NCT07404553

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Nanjing First Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

A Study of SHR-1918 In Participants With Hypertriglyceridemia

NCT07349615

Conditions: Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
Locations: Zhongshan Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days

NCT07614958

Conditions: Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +5 more
Locations: FutureMeds North Tees Stockton-on-Tees, United Kingdom

View Trial Details

Recruiting

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

NCT07581808

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
Locations: University Medical Centre Ljubljana Ljubljana, Slovenia

View Trial Details